Mark Walport

Research.com Recognitions

• 2017 - Fellow of the Royal Society of Edinburgh
• 2012 - Member of Academia Europaea
• 2011 - Fellow of the Royal Society, United Kingdom
• Fellow of The Academy of Medical Sciences, United Kingdom
• Member of the Association of American Physicians
• Fellow of The Academy of Medical Sciences, United Kingdom
• Member of the Association of American Physicians
• Fellow of The Academy of Medical Sciences, United Kingdom
• Member of the Association of American Physicians
• Fellow of The Academy of Medical Sciences, United Kingdom
• Member of the Association of American Physicians

Overview

Best Publications

• Complement. First of two parts.

  Mark J. Walport

  4514
  Citations

• Grand challenges in global mental health

  Pamela Y. Collins;Vikram Patel;Vikram Patel;Sarah S. Joestl;Dana March;Dana March

  2508
  Citations

• Complement. Second of two parts.

  Mark J. Walport

  2192
  Citations

• Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.

  John S Savill;Andrew H. Wyllie;Janet E Henson;Mark J Walport

  1915
  Citations

• Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

  M Botto;C Dell'Agnola;A E Bygrave;E M Thompson

  1701
  Citations

• A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.

  Philip R. Taylor;Anna Carugati;Valerie A. Fadok;H. Terence Cook

  881
  Citations

• Arthritis Critically Dependent on Innate Immune System Players

  Hong Ji;Koichiro Ohmura;Koichiro Ohmura;Umar Mahmood;David M Lee

  835
  Citations

• The Role of Complement in the Development of Systemic Lupus Erythematosus

  Anthony P Manderson;Marina Botto;Mark J Walport

  730
  Citations

• Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity.

  M.C.M. Bickerstaff;M. Botto;W.L. Hutchinson;J. Herbert

  639
  Citations

• Role of Surfactant Proteins A, D, and C1q in the Clearance of Apoptotic Cells In Vivo and In Vitro: Calreticulin and CD91 as a Common Collectin Receptor Complex

  R. William Vandivier;Carol Anne Ogden;Valerie A. Fadok;Peter R. Hoffmann

  630
  Citations

• Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H

  Matthew C. Pickering;H. Terence Cook;Joanna Warren;Anne E. Bygrave

  624
  Citations

• Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

  A H Fielder;M J Walport;J R Batchelor;R I Rynes

  619
  Citations

• The Immune System in Health and Disease

  Charles A Janeway;Paul Travers;Mark Walport;Mark J Shlomchik

  616
  Citations

• Systemic lupus erythematosus, complement deficiency, and apoptosis.

  M C Pickering;M Botto;P R Taylor;P J Lachmann

  609
  Citations

• C1q and systemic lupus erythematosus.

  Mark J. Walport;Kevin A. Davies;Marina Botto

  540
  Citations

• The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice

  Jeremy S. Brown;Tracy Hussell;Sarah M. Gilliland;David W. Holden

  488
  Citations

• Complement deficiency and disease.

  B.Paul Morgan;Mark J Walport

  445
  Citations

• Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.

  C. Marguerie;C. C. Bunn;H. L. C. Beynon;R. M. Bernstein

  441
  Citations

• C1q, autoimmunity and apoptosis.

  Marina Botto;Mark J Walport

  406
  Citations

• Complement facilitates early prion pathogenesis.

  M A Klein;P S Kaeser;P Schwarz;H Weyd

  404
  Citations

• Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.

  G D Ross;W J Yount;M J Walport;J B Winfield

  402
  Citations